| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |